» Authors » Gentiana Vukatana

Gentiana Vukatana

Explore the profile of Gentiana Vukatana including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 48
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Marchesoni A, Macchioni P, Ciancio G, Sandri G, Zabotti A, Montaguti L, et al.
Joint Bone Spine . 2025 Feb; :105877. PMID: 40015358
Objective: Dose reduction of biologic drugs in patients with psoriatic arthritis (PsA) who are in Minimal Disease Activity (MDA) is now considered a feasible option. This study evaluated which baseline...
2.
Di Matteo A, Di Donato S, Smerilli G, Becciolini A, Camarda F, Cauli A, et al.
Arthritis Rheumatol . 2024 Aug; 77(1):22-33. PMID: 39165013
Objective: The study objectives were (i) to explore the agreement between the Outcome Measures in Rheumatology (OMERACT) ultrasound lesions of enthesitis and physical examination in assessing enthesitis in patients with...
3.
Di Matteo A, Smerilli G, Di Donato S, Liu A, Becciolini A, Camarda F, et al.
Ann Rheum Dis . 2024 Mar; 83(7):847-857. PMID: 38443140
Objectives: To assess, in spondyloarthritis (SpA), the discriminative value of the Outcome Measures in Rheumatology (OMERACT) ultrasound lesions of enthesitis and their associations with clinical features in this population. Methods:...
4.
Di Matteo A, Moscioni E, Lommano M, Cipolletta E, Smerilli G, Farah S, et al.
Front Med (Lausanne) . 2023 Feb; 9:1090468. PMID: 36733934
Objectives: To investigate the inter/intra-reliability of ultrasound (US) muscle echogenicity in patients with rheumatic diseases. Methods: Forty-two rheumatologists and 2 radiologists from 13 countries were asked to assess US muscle...
5.
Macchioni P, Marchesoni A, Ciancio G, Sandri G, Zabotti A, Vukatana G, et al.
Front Med (Lausanne) . 2023 Jan; 9:1096547. PMID: 36606060
Background: In psoriatic arthritis (PsA), low disease activity as defined by the Minimal Disease Activity (MDA) index is considered a good treatment target. However, as MDA is based only on...
6.
Di Matteo A, Cipolletta E, Destro Castaniti G, Smerilli G, Airoldi C, Aydin S, et al.
Rheumatology (Oxford) . 2022 Mar; 61(12):4863-4874. PMID: 35293988
Objectives: To investigate the reliability of the OMERACT US Task Force definition of US enthesitis in SpA. Methods: In this web exercise, based on the evaluation of 101 images and...
7.
Bertolini E, Macchioni P, Rizzello F, Salice M, Vukatana G, Sandri G, et al.
Semin Arthritis Rheum . 2020 Feb; 50(3):436-443. PMID: 32061429
Aims: To evaluate the prevalence of clinical and ultrasonographic musculoskeletal involvement in Italian patients with inflammatory bowel disease (IBD). Methods: In this cross-sectional multicenter study, 148 consecutive patients with IBD...
8.
Versura P, Giannaccare G, Vukatana G, Mule R, Malavolta N, Campos E
Ann Clin Biochem . 2018 Jan; 55(5):561-570. PMID: 29310465
Background The contribution of tear protein expression in patients with presumed diagnosis of Sjögren syndrome is underestimated. We aimed to evaluate the role of tear proteins in the Sjögren syndrome...
9.
Gamal N, Brodosi L, Misciali C, Patrizi A, Vukatana G, Malavolta N, et al.
Ann Hepatol . 2014 Feb; 13(2):293-6. PMID: 24558223
For the last decade, the combination therapy of pegylated interferon (Peg-IFN) plus ribavirin (RBV) has been considered as the standard of care treatment for chronic hepatitis C virus (HCV) infection....
10.
Manfredi A, Sebastiani M, Carraro V, Iudici M, Bocci M, Vukatana G, et al.
Clin Hemorheol Microcirc . 2014 Jan; 59(2):133-43. PMID: 24464851
Background: Digital ulcers (DU) affect 50% of systemic sclerosis (SSc) patients, representing a challenging clinical problem. Despite a high negative predictive value, capillaroscopic scores proposed to select patients at risk...